Evidence map›Paper›PMID 36839668›Full record

ArticlePharmaceutics2023

Data-Driven Prediction of the Formation of Co-Amorphous Systems.

Elisabeth Fink, Michael Brunsteiner, Stefan Mitsche, Hartmuth Schröttner, Amrit Paudel, Sarah Zellnitz-Neugebauer

Abstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Calorimetric Monitoring of the Sub-TMolecules (Basel, Switzerland) · 2025
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elisabeth FinkResearch Center Pharmaceutical Engineering, Inffeldgasse 13, 8010 Graz, Austria.
Michael BrunsteinerCeleris Therapeutics GmbH, Salzamtsgasse 7, 8010 Graz, Austria.
Stefan MitscheInstitute of Electron Microscopy and Nanoanalysis (FELMI), Graz University of Technology, Steyrergasse 17, 8010 Graz, Austria.
Hartmuth SchröttnerInstitute of Electron Microscopy and Nanoanalysis (FELMI), Graz University of Technology, Steyrergasse 17, 8010 Graz, Austria.
Amrit PaudelResearch Center Pharmaceutical Engineering, Inffeldgasse 13, 8010 Graz, Austria.ORCID 0000-0002-3325-7828
Sarah Zellnitz-NeugebauerResearch Center Pharmaceutical Engineering, Inffeldgasse 13, 8010 Graz, Austria.

Funding

FWF Austrian Science Fund HF T1105
6 · The paper itself

Abstract

Co-amorphous systems (COAMS) have raised increasing interest in the pharmaceutical industry, since they combine the increased solubility and/or faster dissolution of amorphous forms with the stability of crystalline forms. However, the choice of the co-former is critical for the formation of a COAMS. While some models exist to predict the potential formation of COAMS, they often focus on a limited group of compounds. Here, four classes of combinations of an active pharmaceutical ingredient (API) with (1) another API, (2) an amino acid, (3) an organic acid, or (4) another substance were considered. A model using gradient boosting methods was developed to predict the successful formation of COAMS for all four classes. The model was tested on data not seen during training and predicted 15 out of 19 examples correctly. In addition, the model was used to screen for new COAMS in binary systems of two APIs for inhalation therapy, as diseases such as tuberculosis, asthma, and COPD usually require complex multidrug-therapy. Three of these new API-API combinations were selected for experimental testing and co-processed via milling. The experiments confirmed the predictions of the model in all three cases. This data-driven model will facilitate and expedite the screening phase for new binary COAMS.

Indexed as

co-amorphousgradient boostinginhalation therapymachine learningmolecular descriptors

Identifiers

PMID36839668
PMCPMC9968185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.